Koers Urologix, Inc. Other OTC
Aandelen
ULGX
US9172731047
Geavanceerde medische apparatuur & technologie
Omzet 2013 | 16,48 mln. 15,22 mln. | Omzet 2014 | 14,01 mln. 12,94 mln. | Marktkapitalisatie | 3,66 mln. 3,38 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2013 | -4 mln. -3,69 mln. | Nettowinst (verlies) 2014 | -7 mln. -6,46 mln. | EV/omzet 2013 | 0,4 x |
Nettoschuld 2013 | 3,04 mln. 2,81 mln. | Nettoschuld 2014 | 4,62 mln. 4,26 mln. | EV/omzet 2014 | 0,59 x |
K/w-verhouding 2013 |
-0,8
x | K/w-verhouding 2014 |
-0,49
x | Werknemers | - |
Dividendrendement 2013 * |
-
| Dividendrendement 2014 |
-
| Vrij verhandelbaar | 100% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Mitchell Dann
FOU | Founder | 63 | 29-05-91 |
Scott Madson
DFI | Director of Finance/CFO | 63 | 01-04-15 |
Lisa Ackermann
SAM | Sales & Marketing | 51 | 16-06-11 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Mitchell Dann
FOU | Founder | 63 | 29-05-91 |
Sidney Emery
BRD | Director/Board Member | 74 | 01-10-05 |
Director/Board Member | 57 | 06-08-10 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+11,31% | 225 mld. | |
+15,50% | 197 mld. | |
+18,83% | 143 mld. | |
+30,38% | 111 mld. | |
+2,62% | 64,72 mld. | |
+18,31% | 54,44 mld. | |
+4,96% | 51,06 mld. | |
+9,95% | 45,03 mld. | |
+4,27% | 37,4 mld. |